ocrelizumab

Ligand id: 7580

Name: ocrelizumab

Immunopharmacology Disease
Disease X-Refs Comment References
Relapsing-remitting multiple sclerosis Disease Ontology: DOID:2378
Ocrelizumab is approved to treat RRMS.
Primary progressive multiple sclerosis Disease Ontology: DOID:0050784
Ocrelizumab is approved to treat PPMS.